|
15 Jan 2019 |
Biomunex Pharmaceuticals signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
|
|
10 Jan 2019 |
SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
|
|
10 Jan 2019 |
Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging
|
|
10 Jan 2019 |
Daiichi Sankyo, Mitsubishi UFJ Capital and Tokyo Institute of Technology Announce Open Innovation Research on iPS Cell-derived Insulin Producing Cells in Japan
|
|
09 Jan 2019 |
Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices
|
|
08 Jan 2019 |
Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
|
|
07 Jan 2019 |
bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies
|
|
07 Jan 2019 |
Integral Molecular Enters Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo
|
|
07 Jan 2019 |
3SBio and Samsung Bioepis enter biosimilar collaboration agreement
|
|
07 Jan 2019 |
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
|
|
05 Jan 2019 |
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
|
|
05 Jan 2019 |
Synaffix Announces License Agreement with Mersana Therapeutics for the Use of its GlycoConnect™ Site-Specific ADC Technology
|
|
05 Jan 2019 |
Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer
|
|
05 Jan 2019 |
Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
|
|
05 Jan 2019 |
Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe
|
|
05 Jan 2019 |
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
|
|
05 Jan 2019 |
Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
|
|
03 Jan 2019 |
Atara Biotherapeutics Exclusively Licenses Mesothelin-Targeted CAR T Immunotherapy for Solid Tumors
|
|
03 Jan 2019 |
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
|
|
03 Jan 2019 |
Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
|
|
03 Jan 2019 |
AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39
|
|
03 Jan 2019 |
Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics
|
|
03 Jan 2019 |
Kashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciences
|
|
03 Jan 2019 |
1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma
|
|
03 Jan 2019 |
Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder
|
